Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-03-30

AUTHORS

Ryohei Norioka, Keizo Sugaya, Aki Murayama, Tomoya Kawazoe, Shinsuke Tobisawa, Akihiro Kawata, Kazushi Takahashi

ABSTRACT

BackgroundSpinocerebellar ataxia type 31 (SCA31) is caused by non-coding pentanucleotide repeat expansions in the BEAN1 gene. Clinically, SCA31 is characterized by late adult-onset, pure cerebellar ataxia. To explore the association between parkinsonism and SCA31, five patients with SCA31 with concomitant nigrostriatal dopaminergic dysfunction (NSDD) development, including three cases of L-DOPA responsive parkinsonism, were analyzed.MethodsTo assess regional brain atrophy, cross-sectional and longitudinal imaging analyses were retrospectively performed using magnetic resonance imaging (MRI) planimetry. The midbrain-to-pons (M/P) area ratio and cerebellar area were measured on midsagittal T1-weighted MRI in five patients with SCA31 with concomitant NSDD (NSDD(+)), 14 patients with SCA31 without NSDD (NSDD(−)), 32 patients with Parkinson’s disease (PD), and 15 patients with progressive supranuclear palsy (PSP). Longitudinal changes in the M/P area ratio were assessed by serial MRI of NSDD(+) (n = 5) and NSDD(−) (n = 9).ResultsThe clinical characteristics assessed in the five patients with NSDD were as follows: the mean age at NSDD onset (72.0 ± 10.8 years), prominence of bradykinesia/akinesia (5/5), rigidity (4/5), tremor (2/5), dysautonomia (0/5), vertical gaze limitation (1/5), and abnormalities on 123I-ioflupane dopamine transporter scintigraphy (3/3) and 3-Tesla neuromelanin MRI (4/4). A clear reduction in the midbrain area and the M/P area ratio was observed in the NSDD(+) group (p < 0.05) while there was no significant difference in disease duration or in the pons area among the NSDD(+), NSDD(−), and PD groups. There was also a significant difference in the midbrain and pons area between NSDD(+) and PSP (p < 0.05). Thus, mild but significant midbrain atrophy was observed in NSDD(+). A faster rate of decline in the midbrain area and the M/P area ratio was evident in NSDD(+) (p < 0.05).ConclusionThe clinical characteristics of the five patients with SCA31 with concomitant NSDD, together with the topographical pattern of atrophy, were inconsistent with PD, PSP, and multiple system atrophy, suggesting that SCA31 may manifest NSDD in association with the pathomechanisms underlying SCA31. More... »

PAGES

11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40673-021-00134-4

DOI

http://dx.doi.org/10.1186/s40673-021-00134-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1136792646

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33785066


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Norioka", 
        "givenName": "Ryohei", 
        "id": "sg:person.016601442063.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016601442063.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugaya", 
        "givenName": "Keizo", 
        "id": "sg:person.0661706706.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661706706.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murayama", 
        "givenName": "Aki", 
        "id": "sg:person.015345111603.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015345111603.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawazoe", 
        "givenName": "Tomoya", 
        "id": "sg:person.01365410331.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365410331.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tobisawa", 
        "givenName": "Shinsuke", 
        "id": "sg:person.01121612173.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121612173.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawata", 
        "givenName": "Akihiro", 
        "id": "sg:person.01310226702.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310226702.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Kazushi", 
        "id": "sg:person.01007005571.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007005571.72"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12883-020-01723-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1126671379", 
          "https://doi.org/10.1186/s12883-020-01723-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10038-006-0385-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000664226", 
          "https://doi.org/10.1007/s10038-006-0385-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12311-016-0793-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031398086", 
          "https://doi.org/10.1007/s12311-016-0793-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10048-010-0245-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030990981", 
          "https://doi.org/10.1007/s10048-010-0245-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature22386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085723781", 
          "https://doi.org/10.1038/nature22386"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-03-30", 
    "datePublishedReg": "2021-03-30", 
    "description": "BackgroundSpinocerebellar ataxia type 31 (SCA31) is caused by non-coding pentanucleotide repeat expansions in the BEAN1 gene. Clinically, SCA31 is characterized by late adult-onset, pure cerebellar ataxia. To explore the association between parkinsonism and SCA31, five patients with SCA31 with concomitant nigrostriatal dopaminergic dysfunction (NSDD) development, including three cases of L-DOPA responsive parkinsonism, were analyzed.MethodsTo assess regional brain atrophy, cross-sectional and longitudinal imaging analyses were retrospectively performed using magnetic resonance imaging (MRI) planimetry. The midbrain-to-pons (M/P) area ratio and cerebellar area were measured on midsagittal T1-weighted MRI in five patients with SCA31 with concomitant NSDD (NSDD(+)), 14 patients with SCA31 without NSDD (NSDD(\u2212)), 32 patients with Parkinson\u2019s disease (PD), and 15 patients with progressive supranuclear palsy (PSP). Longitudinal changes in the M/P area ratio were assessed by serial MRI of NSDD(+) (n\u2009=\u20095) and NSDD(\u2212) (n\u2009=\u20099).ResultsThe clinical characteristics assessed in the five patients with NSDD were as follows: the mean age at NSDD onset (72.0\u2009\u00b1\u200910.8\u2009years), prominence of bradykinesia/akinesia (5/5), rigidity (4/5), tremor (2/5), dysautonomia (0/5), vertical gaze limitation (1/5), and abnormalities on 123I-ioflupane dopamine transporter scintigraphy (3/3) and 3-Tesla neuromelanin MRI (4/4). A clear reduction in the midbrain area and the M/P area ratio was observed in the NSDD(+) group (p\u2009<\u20090.05) while there was no significant difference in disease duration or in the pons area among the NSDD(+), NSDD(\u2212), and PD groups. There was also a significant difference in the midbrain and pons area between NSDD(+) and PSP (p\u2009<\u20090.05). Thus, mild but significant midbrain atrophy was observed in NSDD(+). A faster rate of decline in the midbrain area and the M/P area ratio was evident in NSDD(+) (p\u2009<\u20090.05).ConclusionThe clinical characteristics of the five patients with SCA31 with concomitant NSDD, together with the topographical pattern of atrophy, were inconsistent with PD, PSP, and multiple system atrophy, suggesting that SCA31 may manifest NSDD in association with the pathomechanisms underlying SCA31.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40673-021-00134-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1051116", 
        "issn": [
          "2053-8871"
        ], 
        "name": "Cerebellum & Ataxias", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "progressive supranuclear palsy", 
      "Parkinson's disease", 
      "midbrain atrophy", 
      "clinical characteristics", 
      "pons area", 
      "midbrain area", 
      "type 31", 
      "pons area ratio", 
      "bradykinesia/akinesia", 
      "vertical gaze limitation", 
      "multiple system atrophy", 
      "nigrostriatal dopaminergic dysfunction", 
      "regional brain atrophy", 
      "longitudinal imaging analyses", 
      "L-dopa-responsive parkinsonism", 
      "dopamine transporter scintigraphy", 
      "significant differences", 
      "T1-weighted MRI", 
      "gaze limitation", 
      "dysfunction development", 
      "responsive parkinsonism", 
      "disease duration", 
      "supranuclear palsy", 
      "brain atrophy", 
      "system atrophy", 
      "dopaminergic dysfunction", 
      "mean age", 
      "serial MRI", 
      "PD group", 
      "patients", 
      "cerebellar areas", 
      "atrophy", 
      "P area ratio", 
      "spinocerebellar ataxia type 31", 
      "cerebellar ataxia", 
      "neuromelanin MRI", 
      "pure cerebellar ataxia", 
      "longitudinal changes", 
      "parkinsonism", 
      "pentanucleotide repeat expansion", 
      "MRI", 
      "midbrain", 
      "SCA31", 
      "disease", 
      "topographical patterns", 
      "repeat expansion disorders", 
      "repeat expansion", 
      "imaging analysis", 
      "clear reduction", 
      "association", 
      "palsy", 
      "akinesia", 
      "scintigraphy", 
      "dysautonomia", 
      "group", 
      "dysfunction", 
      "pathomechanism", 
      "expansion disorders", 
      "abnormalities", 
      "ataxia", 
      "tremor", 
      "planimetry", 
      "disorders", 
      "age", 
      "differences", 
      "MethodsTo", 
      "cases", 
      "onset", 
      "duration", 
      "area ratio", 
      "ratio", 
      "faster rate", 
      "area", 
      "decline", 
      "genes", 
      "rate", 
      "reduction", 
      "changes", 
      "characteristics", 
      "patterns", 
      "development", 
      "analysis", 
      "limitations", 
      "prominence", 
      "rigidity", 
      "expansion", 
      "NSDD"
    ], 
    "name": "Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction", 
    "pagination": "11", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1136792646"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40673-021-00134-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33785066"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40673-021-00134-4", 
      "https://app.dimensions.ai/details/publication/pub.1136792646"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_894.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40673-021-00134-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40673-021-00134-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40673-021-00134-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40673-021-00134-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40673-021-00134-4'


 

This table displays all metadata directly associated to this object as RDF triples.

209 TRIPLES      21 PREDICATES      117 URIs      104 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40673-021-00134-4 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author N8490b52eeee94eba9b4e8f0ca3ae87fb
4 schema:citation sg:pub.10.1007/s10038-006-0385-6
5 sg:pub.10.1007/s10048-010-0245-6
6 sg:pub.10.1007/s12311-016-0793-x
7 sg:pub.10.1038/nature22386
8 sg:pub.10.1186/s12883-020-01723-2
9 schema:datePublished 2021-03-30
10 schema:datePublishedReg 2021-03-30
11 schema:description BackgroundSpinocerebellar ataxia type 31 (SCA31) is caused by non-coding pentanucleotide repeat expansions in the BEAN1 gene. Clinically, SCA31 is characterized by late adult-onset, pure cerebellar ataxia. To explore the association between parkinsonism and SCA31, five patients with SCA31 with concomitant nigrostriatal dopaminergic dysfunction (NSDD) development, including three cases of L-DOPA responsive parkinsonism, were analyzed.MethodsTo assess regional brain atrophy, cross-sectional and longitudinal imaging analyses were retrospectively performed using magnetic resonance imaging (MRI) planimetry. The midbrain-to-pons (M/P) area ratio and cerebellar area were measured on midsagittal T1-weighted MRI in five patients with SCA31 with concomitant NSDD (NSDD(+)), 14 patients with SCA31 without NSDD (NSDD(−)), 32 patients with Parkinson’s disease (PD), and 15 patients with progressive supranuclear palsy (PSP). Longitudinal changes in the M/P area ratio were assessed by serial MRI of NSDD(+) (n = 5) and NSDD(−) (n = 9).ResultsThe clinical characteristics assessed in the five patients with NSDD were as follows: the mean age at NSDD onset (72.0 ± 10.8 years), prominence of bradykinesia/akinesia (5/5), rigidity (4/5), tremor (2/5), dysautonomia (0/5), vertical gaze limitation (1/5), and abnormalities on 123I-ioflupane dopamine transporter scintigraphy (3/3) and 3-Tesla neuromelanin MRI (4/4). A clear reduction in the midbrain area and the M/P area ratio was observed in the NSDD(+) group (p < 0.05) while there was no significant difference in disease duration or in the pons area among the NSDD(+), NSDD(−), and PD groups. There was also a significant difference in the midbrain and pons area between NSDD(+) and PSP (p < 0.05). Thus, mild but significant midbrain atrophy was observed in NSDD(+). A faster rate of decline in the midbrain area and the M/P area ratio was evident in NSDD(+) (p < 0.05).ConclusionThe clinical characteristics of the five patients with SCA31 with concomitant NSDD, together with the topographical pattern of atrophy, were inconsistent with PD, PSP, and multiple system atrophy, suggesting that SCA31 may manifest NSDD in association with the pathomechanisms underlying SCA31.
12 schema:genre article
13 schema:isAccessibleForFree true
14 schema:isPartOf N1dc95efd7e504430926a03b4c22a5588
15 Nceaa05d1ff5e4324a8b2e5dbea9f51c5
16 sg:journal.1051116
17 schema:keywords L-dopa-responsive parkinsonism
18 MRI
19 MethodsTo
20 NSDD
21 P area ratio
22 PD group
23 Parkinson's disease
24 SCA31
25 T1-weighted MRI
26 abnormalities
27 age
28 akinesia
29 analysis
30 area
31 area ratio
32 association
33 ataxia
34 atrophy
35 bradykinesia/akinesia
36 brain atrophy
37 cases
38 cerebellar areas
39 cerebellar ataxia
40 changes
41 characteristics
42 clear reduction
43 clinical characteristics
44 decline
45 development
46 differences
47 disease
48 disease duration
49 disorders
50 dopamine transporter scintigraphy
51 dopaminergic dysfunction
52 duration
53 dysautonomia
54 dysfunction
55 dysfunction development
56 expansion
57 expansion disorders
58 faster rate
59 gaze limitation
60 genes
61 group
62 imaging analysis
63 limitations
64 longitudinal changes
65 longitudinal imaging analyses
66 mean age
67 midbrain
68 midbrain area
69 midbrain atrophy
70 multiple system atrophy
71 neuromelanin MRI
72 nigrostriatal dopaminergic dysfunction
73 onset
74 palsy
75 parkinsonism
76 pathomechanism
77 patients
78 patterns
79 pentanucleotide repeat expansion
80 planimetry
81 pons area
82 pons area ratio
83 progressive supranuclear palsy
84 prominence
85 pure cerebellar ataxia
86 rate
87 ratio
88 reduction
89 regional brain atrophy
90 repeat expansion
91 repeat expansion disorders
92 responsive parkinsonism
93 rigidity
94 scintigraphy
95 serial MRI
96 significant differences
97 spinocerebellar ataxia type 31
98 supranuclear palsy
99 system atrophy
100 topographical patterns
101 tremor
102 type 31
103 vertical gaze limitation
104 schema:name Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction
105 schema:pagination 11
106 schema:productId N31d8ab250c2e4bec8f8e05b7a99c3d4d
107 N80977c9aa2a343ba82c2567fa82505a2
108 Nd7293669b9574165bbe123a242bfa90f
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136792646
110 https://doi.org/10.1186/s40673-021-00134-4
111 schema:sdDatePublished 2022-12-01T06:42
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher Ne3e1b20829a6489e82e1c852eace7807
114 schema:url https://doi.org/10.1186/s40673-021-00134-4
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0a844a31e0874c938924e2a6c3e59b57 rdf:first sg:person.0661706706.25
119 rdf:rest Nb5b8c18a87d446c284c89404fe73d269
120 N1dc95efd7e504430926a03b4c22a5588 schema:issueNumber 1
121 rdf:type schema:PublicationIssue
122 N31d8ab250c2e4bec8f8e05b7a99c3d4d schema:name doi
123 schema:value 10.1186/s40673-021-00134-4
124 rdf:type schema:PropertyValue
125 N55fcd589c6a94f048aadb21b8f581a99 rdf:first sg:person.01121612173.12
126 rdf:rest Nc6e00ed5c8da44238cfc7a887cdf9848
127 N6d509786ea204c06bda18ac60188e769 rdf:first sg:person.01007005571.72
128 rdf:rest rdf:nil
129 N80977c9aa2a343ba82c2567fa82505a2 schema:name pubmed_id
130 schema:value 33785066
131 rdf:type schema:PropertyValue
132 N8490b52eeee94eba9b4e8f0ca3ae87fb rdf:first sg:person.016601442063.41
133 rdf:rest N0a844a31e0874c938924e2a6c3e59b57
134 Nb5b8c18a87d446c284c89404fe73d269 rdf:first sg:person.015345111603.11
135 rdf:rest Nb6baff4123fa48de9912c4bd632465d4
136 Nb6baff4123fa48de9912c4bd632465d4 rdf:first sg:person.01365410331.16
137 rdf:rest N55fcd589c6a94f048aadb21b8f581a99
138 Nc6e00ed5c8da44238cfc7a887cdf9848 rdf:first sg:person.01310226702.10
139 rdf:rest N6d509786ea204c06bda18ac60188e769
140 Nceaa05d1ff5e4324a8b2e5dbea9f51c5 schema:volumeNumber 8
141 rdf:type schema:PublicationVolume
142 Nd7293669b9574165bbe123a242bfa90f schema:name dimensions_id
143 schema:value pub.1136792646
144 rdf:type schema:PropertyValue
145 Ne3e1b20829a6489e82e1c852eace7807 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
151 schema:name Neurosciences
152 rdf:type schema:DefinedTerm
153 sg:journal.1051116 schema:issn 2053-8871
154 schema:name Cerebellum & Ataxias
155 schema:publisher Springer Nature
156 rdf:type schema:Periodical
157 sg:person.01007005571.72 schema:affiliation grid-institutes:grid.417106.5
158 schema:familyName Takahashi
159 schema:givenName Kazushi
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007005571.72
161 rdf:type schema:Person
162 sg:person.01121612173.12 schema:affiliation grid-institutes:grid.417106.5
163 schema:familyName Tobisawa
164 schema:givenName Shinsuke
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121612173.12
166 rdf:type schema:Person
167 sg:person.01310226702.10 schema:affiliation grid-institutes:grid.417106.5
168 schema:familyName Kawata
169 schema:givenName Akihiro
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310226702.10
171 rdf:type schema:Person
172 sg:person.01365410331.16 schema:affiliation grid-institutes:grid.417106.5
173 schema:familyName Kawazoe
174 schema:givenName Tomoya
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365410331.16
176 rdf:type schema:Person
177 sg:person.015345111603.11 schema:affiliation grid-institutes:grid.417106.5
178 schema:familyName Murayama
179 schema:givenName Aki
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015345111603.11
181 rdf:type schema:Person
182 sg:person.016601442063.41 schema:affiliation grid-institutes:grid.417106.5
183 schema:familyName Norioka
184 schema:givenName Ryohei
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016601442063.41
186 rdf:type schema:Person
187 sg:person.0661706706.25 schema:affiliation grid-institutes:grid.417106.5
188 schema:familyName Sugaya
189 schema:givenName Keizo
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661706706.25
191 rdf:type schema:Person
192 sg:pub.10.1007/s10038-006-0385-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000664226
193 https://doi.org/10.1007/s10038-006-0385-6
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/s10048-010-0245-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030990981
196 https://doi.org/10.1007/s10048-010-0245-6
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/s12311-016-0793-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031398086
199 https://doi.org/10.1007/s12311-016-0793-x
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/nature22386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085723781
202 https://doi.org/10.1038/nature22386
203 rdf:type schema:CreativeWork
204 sg:pub.10.1186/s12883-020-01723-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1126671379
205 https://doi.org/10.1186/s12883-020-01723-2
206 rdf:type schema:CreativeWork
207 grid-institutes:grid.417106.5 schema:alternateName Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan
208 schema:name Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, 183-0042, Tokyo, Japan
209 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...